CN1893920A - 碱性药用活性物质的泡腾制剂 - Google Patents

碱性药用活性物质的泡腾制剂 Download PDF

Info

Publication number
CN1893920A
CN1893920A CNA2004800373887A CN200480037388A CN1893920A CN 1893920 A CN1893920 A CN 1893920A CN A2004800373887 A CNA2004800373887 A CN A2004800373887A CN 200480037388 A CN200480037388 A CN 200480037388A CN 1893920 A CN1893920 A CN 1893920A
Authority
CN
China
Prior art keywords
effervescent formulation
acid
bicarbonate
pseudoephedrine
basic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800373887A
Other languages
English (en)
Chinese (zh)
Inventor
W·维尔
I·洛泽
R·比勒斯巴赫
D·勒恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of CN1893920A publication Critical patent/CN1893920A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
CNA2004800373887A 2003-12-19 2004-12-07 碱性药用活性物质的泡腾制剂 Pending CN1893920A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10359790A DE10359790A1 (de) 2003-12-19 2003-12-19 Brausezubereitung einer basischen arzneilich wirksamen Substanz
DE10359790.5 2003-12-19

Publications (1)

Publication Number Publication Date
CN1893920A true CN1893920A (zh) 2007-01-10

Family

ID=34683574

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800373887A Pending CN1893920A (zh) 2003-12-19 2004-12-07 碱性药用活性物质的泡腾制剂

Country Status (16)

Country Link
EP (1) EP1696874A1 (no)
JP (1) JP2007515418A (no)
KR (1) KR20060109492A (no)
CN (1) CN1893920A (no)
AR (1) AR046955A1 (no)
AU (1) AU2004308590A1 (no)
BR (1) BRPI0417796A (no)
CA (1) CA2550342A1 (no)
DE (1) DE10359790A1 (no)
EC (1) ECSP066649A (no)
IL (1) IL176356A0 (no)
MA (1) MA28276A1 (no)
MX (1) MXPA06006658A (no)
NO (1) NO20063327L (no)
WO (1) WO2005063199A1 (no)
ZA (1) ZA200604946B (no)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102438598A (zh) * 2009-05-27 2012-05-02 株式会社茶山医化 含有泡腾层的多层片
CN104622831A (zh) * 2013-11-06 2015-05-20 江苏豪森药业股份有限公司 一种口服片剂及其制备方法
CN107951034A (zh) * 2017-12-01 2018-04-24 郑州拓洋生物工程有限公司 维生素泡腾制剂及其制备方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9078824B2 (en) 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
TR201107202T1 (tr) * 2008-11-11 2012-02-21 Berko İlaç Ve Ki̇mya Sanayi̇ A.Ş. İbuprofen, psödoefedrin ve klorfeniramin içeren bir farmasötik bileşim.
WO2013109224A1 (en) * 2012-01-18 2013-07-25 Mahmut Bilgic Pharmaceutical compositions comprising diclofenac

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
CA2084028A1 (en) * 1991-11-27 1993-05-28 Harish B. Pandya Hot flu composition
AU7407194A (en) * 1993-08-03 1995-02-28 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
JP2000063269A (ja) * 1998-08-20 2000-02-29 Taiho Yakuhin Kogyo Kk 固形製剤

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102438598A (zh) * 2009-05-27 2012-05-02 株式会社茶山医化 含有泡腾层的多层片
CN102438598B (zh) * 2009-05-27 2015-06-10 株式会社茶山医化 含有泡腾层的多层片
CN104958273A (zh) * 2009-05-27 2015-10-07 株式会社茶山医化 含有泡腾层的多层片
CN104958273B (zh) * 2009-05-27 2017-10-13 株式会社茶山医化 含有泡腾层的多层片
CN104622831A (zh) * 2013-11-06 2015-05-20 江苏豪森药业股份有限公司 一种口服片剂及其制备方法
CN107951034A (zh) * 2017-12-01 2018-04-24 郑州拓洋生物工程有限公司 维生素泡腾制剂及其制备方法

Also Published As

Publication number Publication date
AR046955A1 (es) 2006-01-04
NO20063327L (no) 2006-07-18
AU2004308590A1 (en) 2005-07-14
IL176356A0 (en) 2006-10-05
ZA200604946B (en) 2007-09-26
KR20060109492A (ko) 2006-10-20
CA2550342A1 (en) 2005-07-14
MXPA06006658A (es) 2006-08-31
BRPI0417796A (pt) 2007-03-20
DE10359790A1 (de) 2005-07-21
WO2005063199A1 (de) 2005-07-14
ECSP066649A (es) 2006-10-25
EP1696874A1 (de) 2006-09-06
JP2007515418A (ja) 2007-06-14
MA28276A1 (fr) 2006-11-01

Similar Documents

Publication Publication Date Title
CN1201822C (zh) 含有拟交感神经胺盐的不适合非法使用的组合物
US20090023744A1 (en) Combination therapy for depression
CN1134665A (zh) 含有血管紧张素转化酶抑制剂雷米普利和二氢吡啶类化合物的新药物组合物
CN1617708A (zh) 味道掩蔽的水性液体药物组合物
CN1292703A (zh) 发泡性肠溶制剂
JP2012513955A (ja) 経口投与剤形
CN1525851A (zh) 抗滥用阿片样物质控释剂型
CN1267215A (zh) 含有泡腾酸碱对的药物组合物
CN87105828A (zh) 苏灵大或苏灵大钠和碱的速效组合物
CN1863517A (zh) 快速崩解制剂
CN101073563A (zh) 一种含有右旋布洛芬和左旋西替利嗪的手性组合物及其缓速释双层片
CN1921836A (zh) 口服递送用多粒子制剂
WO2006089493A1 (es) Comprimido multicapa con capas que se separan
JP7243876B2 (ja) 固形製剤
CN1520285A (zh) 包含西替利嗪和伪麻黄碱的片剂
CN1387433A (zh) 磷酸二酯酶4抑制剂的给药方法
CN1893920A (zh) 碱性药用活性物质的泡腾制剂
CN1538837A (zh) 含有对乙酰氨基酚的吞咽片
KR20190019061A (ko) 지연된 방출 경구 탐술로신 하이드로클로라이드
US20070048375A1 (en) Effervescent preparation of a basic medicinally active substance
US20080187589A1 (en) Multi-modal delivery via transmucosal and gastro-intestinal absorption of antihistamines and symptom relief
CN1443535A (zh) 马来酸替加色罗口服制剂及其制备工艺——治疗肠易惹综合征
CN1188131C (zh) 苯二氮卓类药物口服脉冲释药***及其制备方法
CN1726027A (zh) 包含曲马多和托吡酯的控释制剂
CN1265785C (zh) 盐酸维拉帕米择时缓释制剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1102916

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20070110

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1102916

Country of ref document: HK